Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Hong Kong Test Shows Efficacy of Early Cancer Liquid Biopsy Testing

publication date: Aug 10, 2017
A group of Hong Kong researchers have shown the viability of "liquid biopsy" early cancer screening in a large trial. Dennis Lo, PhD, the founder of Hong Kong cancer screening company Cirina, along with associates at Hong Kong University, conducted a three-year test among 20,000 men for nasopharyngeal cancer. 34 cases were discovered, and 71% of the cases were still at an early stage of development. The results were published in The New England Journal of Medicine. In June, Cirina merged into Grail, a California company that has raised $1 billion to develop early screening tests for cancer. More details....

Share this with colleagues:



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital